Information  X 
Enter a valid email address

Bioventix profit nudges up 1% on higher antibody sales

By BFN News | 01:41 PM | Monday 21 October, 2019

Antibody supplier Bioventix posted a 1% rise in annual profit amid rising sales of a vitamin D antibody to diagnostic companies. Pre-tax profit for the year through June rose to £7.0m, up from £6.9m on-year. Revenue rose 6% to 6% to £9.3m. Bioventix declared a second interim dividend of 43p per share, up from 36p on-year, plus a special dividend of 47p per share, down from 55p on-year. At 1:41pm: (LON:BVXP) Bioventix Plc share price was -175p at 3385p Story provided by

a d v e r t i s e m e n t